XML 51 R29.htm IDEA: XBRL DOCUMENT v3.19.3
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
9 Months Ended
Sep. 30, 2019
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2019
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
9,480

 
$
210,707

 
$
(103,523
)
 
$

 
$
116,664

Investing activities:

 

 

 

 

Capital expenditures

 
(13,269
)
 
(17,054
)
 

 
(30,323
)
Acquisition payments

 
(27,742
)
 

 

 
(27,742
)
Dividends received from subsidiaries

 
67,065

 

 
(67,065
)
 

Other

 
(210,320
)
 
4,575

 
210,320

 
4,575

Net cash used in investing activities

 
(184,266
)
 
(12,479
)
 
143,255

 
(53,490
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
143,255

 
333,418

 
856,464

 
(210,320
)
 
1,122,817

Repayments

 
(344,167
)
 
(630,263
)
 

 
(974,430
)
Repurchases of common stock
(152,735
)
 

 

 

 
(152,735
)
Dividends paid by subsidiaries

 

 
(67,065
)
 
67,065

 

Other

 
(13,734
)
 

 

 
(13,734
)
Net cash (used in) provided by financing activities
(9,480
)
 
(24,483
)
 
159,136

 
(143,255
)
 
(18,082
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(3,275
)
 

 
(3,275
)
Net change in cash and cash equivalents

 
1,958

 
39,859

 

 
41,817

Cash and cash equivalents at the beginning of period

 
35,931

 
60,412

 

 
96,343

Cash and cash equivalents at the end of period
$

 
$
37,889

 
$
100,271

 
$

 
$
138,160


 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
14,198

 
$
62,439

 
$
97,823

 
$

 
$
174,460

Investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(12,831
)
 
(10,918
)
 

 
(23,749
)
Dividends received from subsidiaries

 
118,271

 

 
(118,271
)
 

Other

 
(81,128
)
 
3,609

 
81,128

 
3,609

Net cash provided by (used in) investing activities

 
24,312

 
(7,309
)
 
(37,143
)
 
(20,140
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
12,857

 
246,323

 
933,046

 
(81,128
)
 
1,111,098

Repayments

 
(318,323
)
 
(882,239
)
 

 
(1,200,562
)
Repurchases of common stock
(27,055
)
 

 

 

 
(27,055
)
Dividends paid by subsidiaries

 

 
(118,271
)
 
118,271

 

Other

 
(8,301
)
 

 

 
(8,301
)
Net cash used in financing activities
(14,198
)
 
(80,301
)
 
(67,464
)
 
37,143

 
(124,820
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(4,693
)
 

 
(4,693
)
Net change in cash and cash equivalents

 
6,450

 
18,357

 

 
24,807

Cash and cash equivalents at the beginning of period

 
50,602

 
67,351

 

 
117,953

Cash and cash equivalents at the end of period
$

 
$
57,052

 
$
85,708

 
$

 
$
142,760